Athyros V - Search Results

1

SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature.

Patoulias D, Imprialos K, Stavropoulos K, Athyros V, Doumas M. Patoulias D, et al. Among authors: athyros v. Curr Clin Pharmacol. 2018;13(4):261-272. doi: 10.2174/1574884713666180807150509. Curr Clin Pharmacol. 2018. PMID: 30084335 Review.

2

Statins and renal function in patients with diabetes mellitus.

Athyros VG, Papageorgiou AA, Elisaf M, Mikhailidis DP; GREACE Study Collaborative Group. Athyros VG, et al. Curr Med Res Opin. 2003;19(7):615-7. doi: 10.1185/030079903125002315. Curr Med Res Opin. 2003. PMID: 14606984 Clinical Trial.

3

Atherogenesis in renal patients: a model of vascular disease?

Efstratiadis G, Tziomalos K, Mikhailidis DP, Athyros VG, Hatzitolios A. Efstratiadis G, et al. Curr Vasc Pharmacol. 2008 Apr;6(2):93-107. doi: 10.2174/157016108783955374. Curr Vasc Pharmacol. 2008. PMID: 18393910 Review.

4

Pleiotropic effects of statins--clinical evidence.

Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Curr Pharm Des. 2009;15(5):479-89. doi: 10.2174/138161209787315729. Curr Pharm Des. 2009. PMID: 19199976 Review.

5

Should adipokines be considered in the choice of the treatment of obesity-related health problems?

Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Athyros VG, et al. Curr Drug Targets. 2010 Jan;11(1):122-35. doi: 10.2174/138945010790030992. Curr Drug Targets. 2010. PMID: 20017725 Review.

6

Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?

Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A. Anagnostis P, et al. Curr Vasc Pharmacol. 2010 Sep;8(5):720-30. doi: 10.2174/157016110792006978. Curr Vasc Pharmacol. 2010. PMID: 20180765 Review.

7

The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.

Karagiannis A, Tziomalos K, Anagnostis P, Gossios TD, Florentin M, Athyros VG, Mikhailidis DP. Karagiannis A, et al. Curr Vasc Pharmacol. 2010 Nov;8(6):792-803. doi: 10.2174/157016110793563906. Curr Vasc Pharmacol. 2010. PMID: 20626344 Review.

8

Atherosclerotic renal artery stenosis: an update on diagnosis and management.

Stavrinou E, Koumaras C, Gossios TD, Tziomalos K, Athyros VG, Karagiannis A. Stavrinou E, et al. Curr Vasc Pharmacol. 2011 Jul 1;9(4):465-70. doi: 10.2174/157016111796197251. Curr Vasc Pharmacol. 2011. PMID: 21314636 Review.

9

Ezetimibe therapy for dyslipidemia: an update.

Katsiki N, Theocharidou E, Karagiannis A, Athyros VG, Mikhailidis DP. Katsiki N, et al. Curr Pharm Des. 2013;19(17):3107-14. doi: 10.2174/13816128113199990314. Curr Pharm Des. 2013. PMID: 23317398 Review.

10

Colesevelam: a new and improved bile acid sequestrant?

Tziomalos K, Karagiannis A, Mikhailidis DP, Athyros VG. Tziomalos K, et al. Curr Pharm Des. 2013;19(17):3115-23. doi: 10.2174/1381612811319170019. Curr Pharm Des. 2013. PMID: 23317402 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

435 results

Search Page